WO2002038752A3 - Use of a helminth for the in vivo delivery of a medicament - Google Patents

Use of a helminth for the in vivo delivery of a medicament Download PDF

Info

Publication number
WO2002038752A3
WO2002038752A3 PCT/US2001/051212 US0151212W WO0238752A3 WO 2002038752 A3 WO2002038752 A3 WO 2002038752A3 US 0151212 W US0151212 W US 0151212W WO 0238752 A3 WO0238752 A3 WO 0238752A3
Authority
WO
WIPO (PCT)
Prior art keywords
helminth
medicament
vivo delivery
delivery
disclosed
Prior art date
Application number
PCT/US2001/051212
Other languages
French (fr)
Other versions
WO2002038752A2 (en
WO2002038752A8 (en
Inventor
Jonathan Kurtis
Robert H Pierce
Original Assignee
Jonathan Kurtis
Robert H Pierce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jonathan Kurtis, Robert H Pierce filed Critical Jonathan Kurtis
Priority to AU2002234175A priority Critical patent/AU2002234175A1/en
Priority to EP01985205A priority patent/EP1335749A2/en
Priority to CA002433200A priority patent/CA2433200A1/en
Priority claimed from US10/008,340 external-priority patent/US20020090363A1/en
Publication of WO2002038752A2 publication Critical patent/WO2002038752A2/en
Publication of WO2002038752A3 publication Critical patent/WO2002038752A3/en
Publication of WO2002038752A8 publication Critical patent/WO2002038752A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
    • A01K67/0333—Genetically modified invertebrates, e.g. transgenic, polyploid
    • A01K67/0335—Genetically modified worms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed herein are helminth-based medical devices for sustained delivery of bioactive agents.
PCT/US2001/051212 2000-11-13 2001-11-13 Use of a helminth for the in vivo delivery of a medicament WO2002038752A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002234175A AU2002234175A1 (en) 2000-11-13 2001-11-13 Use of a helminth for the in vivo delivery of a medicament
EP01985205A EP1335749A2 (en) 2000-11-13 2001-11-13 Use of a helminth for the in vivo delivery of a medicament
CA002433200A CA2433200A1 (en) 2000-11-13 2001-11-13 Use of a helminth for the in vivo delivery of a medicament

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24811300P 2000-11-13 2000-11-13
US60/248,113 2000-11-13
US24811301P 2001-11-13 2001-11-13
US10/008,340 US20020090363A1 (en) 2000-11-13 2001-11-13 Sustained bioactive agent delivery device and methods of making and using the same
US10/008,340 2001-11-13

Publications (3)

Publication Number Publication Date
WO2002038752A2 WO2002038752A2 (en) 2002-05-16
WO2002038752A3 true WO2002038752A3 (en) 2002-09-26
WO2002038752A8 WO2002038752A8 (en) 2003-02-06

Family

ID=27358586

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/051212 WO2002038752A2 (en) 2000-11-13 2001-11-13 Use of a helminth for the in vivo delivery of a medicament

Country Status (1)

Country Link
WO (1) WO2002038752A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011191A1 (en) * 1995-09-21 1997-03-27 Ira Miller Method of transgene expression and secretion in schistosoma
WO2000009731A1 (en) * 1998-08-14 2000-02-24 Haldane Research Limited Transgenic parasites as gene therapy agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011191A1 (en) * 1995-09-21 1997-03-27 Ira Miller Method of transgene expression and secretion in schistosoma
WO2000009731A1 (en) * 1998-08-14 2000-02-24 Haldane Research Limited Transgenic parasites as gene therapy agents

Also Published As

Publication number Publication date
WO2002038752A2 (en) 2002-05-16
WO2002038752A8 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
HK1048428A1 (en) Ophthalmic drug delivery device.
IL157771A0 (en) Intravaginal drug delivery devices for the administration of an antimicrobial agent
PL368207A1 (en) Ophthalmic drug delivery device
AU5977401A (en) Delivery devices for treatment of vascular disease
AU2001273341A1 (en) An implantable or insertable therapeutic agent delivery device
EP1377232A4 (en) Ocular therapeutic agent delivery devices and methods for making and using such devices
MXPA03007590A (en) Compositions and methods for enhancing drug delivery across and into ocular tissues.
MXPA03003853A (en) Medicament dispenser.
AU2001264887A1 (en) Drug delivery device
AU2001238386A1 (en) Medication delivery devices
AU2002246925A1 (en) Therapeutic delivery balloon
MXPA03004941A (en) Drug formulation having improved oral tolerability.
AU2002335046A1 (en) The use of proton sequestering agents in drug formulations
MXPA03005731A (en) Absorbent article having releasable medicinal treatments.
AU2002213698A1 (en) Needleless syringe for the subcutaneous delivery of therapeutic agents
AU2001296800A1 (en) Systemic delivery of compounds through non-invasive bladder administration
GB2368525B (en) Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
AU2001243515A1 (en) Combination drug therapy
AU2002243290A1 (en) Transluminal drug delivery catheter
AU6503399A (en) Drug delivery catheter
WO2002038752A8 (en) Use of a helminth for the in vivo delivery of a medicament
AU5654701A (en) Drug delivery mask
AU2001244854A1 (en) Local drug delivery
GB0210020D0 (en) Medical agent delivery

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 20/2002 UNDER (30) REPLACE "NOT FURNISHED" BY "10/008340"

WWE Wipo information: entry into national phase

Ref document number: 2002234175

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001985205

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2433200

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2001985205

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001985205

Country of ref document: EP

Ref document number: JP